4
Changes in Ownership
Tyra Biosciences, Inc. Filed Acc 0001193125-25-288529
Chief Operating Officer sold 125,589 shares at an average $16.17 ($2,030,923)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bensen Daniel Chief Operating Officer | 2025-11-18 | Sale 10b5-1 | −75,633 | $16.07 | $1,215,627 | 220,937 | D: show line 1 in the form |
| Bensen Daniel Chief Operating Officer | 2025-11-19 | Sale 10b5-1 | −49,956 | $16.32 | $815,297 | 170,981 | D: show line 2 in the form |
| Open-market sales · 125,589 sh · avg $16.17 · $2,030,923 | |||||||
Loading xslF345X05/ownership.xml…